Background: Black patients are commonly believed to have higher stroke mortality. However, several recent studies have reported better survival in black patients with stroke.
T
he racial disparity in stroke is an enormous public health concern. Compared with white patients, black patients have a greater prevalence of stroke risk factors (1, 2) , experience more severe deficits at stroke onset (3, 4) , are more likely to be hospitalized for stroke, and have less access to specialty care or newer technologies (5) . Numerous appeals have been made for a better understanding of both the underlying reasons for these disparities and the resulting excess burden of disease (6) .
Although vital statistics have documented excess stroke mortality among black persons for decades (7) , several recent studies (8 -11) have suggested a consistent pattern of lower short-term mortality for black patients who are hospitalized for stroke than for white patients, even after adjustment for age and clinical risk factors. This conflicts with the prevailing views that black patients have less access to evidence-based stroke treatments and worse overall quality of care (11) .
Potential reasons offered for this paradox include differences in illness severity and stroke subtypes (11, 12) , survivorship bias (9, 10) , selection bias (13) , different methods of risk adjustment (14) , and different lengths of outcome assessment (15) . However, many deaths that occur shortly after an ischemic stroke are due to the withholding or withdrawing of life-sustaining interventions (16) . In addition, black and white patients are known to have different access to and preferences for treatments and services when they are seriously ill or at the end of life (17) (18) (19) (20) . We therefore examined racial differences in risk for death after hospitalization for acute ischemic stroke and explored the differential use of hyperacute and end-of-life treatments as a possible explanation.
METHODS

Study Population
Our primary data source was hospital administrative data from the New York Statewide Planning and Research Cooperative System (SPARCS), a comprehensive data reporting system that collects detailed information on every hospital and emergency department admission in New York. For this analysis, we included black or white patients not of Hispanic origin, aged 18 years or older, who were hospitalized for acute ischemic stroke between 1 January 2005 and 31 December 2006. An ischemic stroke diagnosis was defined as a principal diagnosis of acute ischemic stroke (International Classification of Diseases, Ninth Revision, Clinical Modification [ICD-9-CM] diagnosis code 433.x1 [occlusion and stenosis of precerebral arteries with cerebral infarction] or 434.x1 [occlusion of cerebral arteries with cerebral infarction]). Our sample was restricted to patients who lived in metropolitan statistical areas, because few black patients reside in the rural areas of New York. After patients who had missing data or resided outside of New York were excluded, our study population comprised 5319 black patients and 18 340 white patients from 164 hospitals in New York (total, 23 659 patients).
Patient Follow-up and Measurements
The SPARCS data were linked to the Social Security Administration Death Master File to follow patients' vital status for 1 year after the initial hospitalization. We examined in-hospital mortality (death occurring during the hospital stay) and all-cause mortality at 30, 90, and 180 days and 1 year.
We condensed the ICD-9-CM procedure codes into procedure categories by using the Agency for Healthcare Research and Quality Healthcare Cost and Utilization Project Clinical Classification Software. The use of 6 potential life-sustaining interventions (respiratory intubation or mechanical ventilation, tracheostomy with mechanical ventilation for at least 96 hours, hemodialysis, cardiopulmonary resuscitation, gastrostomy, and enteral or parenteral nutrition) were examined (21) , as well as discharge to hospice rate, intensive care unit (ICU) admission rate, total length of stay, ICU length of stay, total hospital charges, and use of tissue plasminogen activator. These measures were chosen according to clinical judgment and data availability.
Statistical Analysis
We used the Wilcoxon rank-sum test or the chi-square test, as appropriate, to test for differences between black and white patients. A propensity score method (22) was used to balance baseline characteristics between black and white patients. The propensity score, defined as the probability of being black, was estimated by using a multivariate logistic regression model that included age, sex, health insurance status, family income, principal diagnosis, presence of atrial fibrillation on admission, a modified version of the Charlson Comorbidity Index tailored for ischemic stroke outcome studies (23) , hospital teaching status, hospital bed size, and living distance from the admitting hospital. Comorbid conditions were differentiated from inpatient complications by using the present-on-admission indicator. A secondary diagnosis was identified as a comorbid condition if it was present when the patient was hospitalized, which allowed cleaner adjustment for comorbid conditions and improved mortality risk adjustment (24) . The propensity score model also included hospital indicator variables and hospital-by-characteristic interaction terms. This partial pooling approach incorporated the multilevel structure of the data, in which patients were clustered within hospitals (Appendix, available at www .annals.org) (25) . The propensity scores were converted into deciles and included as a covariate in a Cox proportional hazards model to estimate the effect of race (black vs. white) on mortality. The robust sandwich estimator (26) was used to control for within-hospital clustering. Because age is a major determinant of stroke mortality, our analyses were stratified by age group (18 to 64, 65 to 74, 75 to 84, and Ն85 years), and an adjusted hazard ratio (HR) is reported for each age stratum.
To evaluate the robustness of our findings, the propensity score model was first compared with a direct risk adjustment model that included all of the covariates. The Elixhauser index (27) , an alternate and more comprehensive risk adjustment method that has been proposed for predicting mortality in stroke outcome studies (28) , was then used to control for comorbid conditions.
We examined the influence of race on end-of-life treatment on the basis of the probability of dying in the hospital (21, 29) . A patient's probability of death was estimated from a multivariate logistic regression model with patient sociodemographic, disease, and comorbid condition characteristics; hospital characteristics; hospital indicator variables; and 2-way interactions between these variables as independent variables. A c-statistic of 0.86 indicated excellent discrimination of a patient's risk for death during hospitalization on the basis of the model. The estimated probability of dying in the hospital was then included with race as a variable in the logistic regression
Context
Vital statistics consistently show that stroke mortality rates are higher for black persons than for white persons, but recent studies suggest a different pattern for people hospitalized with stroke.
Contribution
Among patients admitted to 164 hospitals in New York during 2005 and 2006, all-cause mortality rates were lower among the 5319 black patients than the 18 340 white patients during hospitalization for ischemic stroke and at 30 days and 1 year after hospitalization.
Caution
The investigators did not have information about the severity of stroke.
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Differences in the use of life-sustaining interventions may explain the differences in mortality rates.
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Racial Differences in Mortality Among Patients With Acute Ischemic Stroke model to predict the probability of receiving end-of-life treatment. Inclusion of the probability of death as a covariate facilitated a parsimonious regression model and captured the racial influence on end-of-life treatment decisions for patients who may be dying. Generalized estimating equations were used to account for within-hospital clustering (30) .
A 2-sided P value less than 0.05 was considered statistically significant. All analyses were performed by using SAS, version 9.2 (SAS Institute, Cary, North Carolina). The University of Rochester Research Subject Review Board approved this study.
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RESULTS
We identified 23 659 patients (5319 black patients and 18 340 white patients) hospitalized for acute ischemic stroke in 164 New York hospitals between 1 January 2005 and 31 December 2006. Table 1 shows the differences in sociodemographic, disease, and hospital characteristics between black and white patients. On average, black patients were somewhat younger and poorer and had a greater prevalence of diabetes and renal disease. Black patients also lived closer to the hospital and were more likely to be admitted to large teaching hospitals. 
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Propensity score adjustment was used to balance the baseline characteristics between black and white patients. To achieve a reliable and stable study sample, we excluded patients with extreme propensity score values (0% or 100% probability of being either black or white) and further restricted our analysis to hospitals that had at least 10 black and 10 white patients. Thus, the propensity score study sample comprised 4238 black patients (80%) and 10 284 white patients (56%) among 71 hospitals (43%) that contributed 14 522 of the available patients (61%). The initial imbalance between black and white patients was not present after adjustment for propensity score deciles (Table 1 ; all adjusted P Ͼ 0.050). The baseline characteristics of the black patients included in the propensity score analysis were similar to those of the entire sample of black patients. However, the entire sample of white patients was older and had more comorbid conditions than the subsample of white patients used in the propensity score analysis (Appendix).
Racial Differences in Mortality
In unadjusted analyses ( Table 2) , black patients had a lower in-hospital mortality rate than white patients (5.0% vs. 7.4%; unadjusted odds ratio [OR], 0.65 [95% CI, 0.56 to 0.77]). Black patients also had consistently lower 30-day to 1-year all-cause mortality rates than white patients (all P Ͻ 0.001). The cumulative hazard plots showed more favorable survival in black patients (Figure 1 ). After adjustment for propensity score deciles, black race was still independently associated with lower in-hospital mortality rates and 30-day to 1-year all-cause mortality rates. These mortality differences are reflected in the attenuated adjusted OR over time, from 0.69 at 30 days to 0.86 at 1 year. In the Cox proportional hazards model, the adjusted HR of death for black patients relative to white patients was 0.87 (CI, 0.79 to 0.96), which indicates lower mortality among black patients. No evidence indicated that the proportional hazards assumption was violated (Appendix). We observed a consistent pattern of lower risk for death for black patients in each age stratum, although the CIs were wide and not statistically significant (Figure 2) .
The direct risk-adjusted Cox model, which included all of the covariates in the study population, demonstrated similar mortality differences (adjusted HR, 0. 
Racial Differences in End-Of-Life Care
In the unadjusted analysis, black patients were more likely than white patients to receive more aggressive lifesustaining interventions but less likely to be admitted to an ICU or hospice ( Table 3) . After adjustment for the probability of dying in the hospital, black race was independently associated with more aggressive end-of-life treatment, including tracheostomy with mechanical ventilation for at least 96 hours (adjusted OR, 1.53 [CI, 1.11 to 
DISCUSSION
In this large cohort of patients with acute ischemic stroke, we found that black patients had lower in-hospital mortality rates and all-cause mortality rates than white patients for up to 1 year after stroke onset. The survival difference persisted after we controlled for the observed confounders in propensity score analyses and used a regular risk-adjustment model that included all of the covariates.
These data highlight the difference between stroke mortality and case-fatality rates. Compared with white persons, black persons have excess overall stroke-related mortality because of higher stroke incidence (31, 32) . Conflicting data have been reported on stroke case-fatality by race (6, 32, 33) , but increasing evidence from hospital administrative data (9, 10) and stroke registries (8, 11) suggests that patients from racial or ethnic minority groups have a lower risk for all-cause mortality after being hospitalized for stroke than white patients.
We found that black patients with stroke received lifesustaining interventions more often and had longer lengths of stay, higher hospital spending, and a lower hospice admission rate. Our data are consistent with previous research (17) (18) (19) 34) that shows that black patients more often receive life-sustaining interventions, including gastrostomy, hemodialysis, and intubation and tracheostomy, than nonblack patients. In addition, black patients are less likely to access palliative care services or hospice (16, 18, * Propensity score was calculated by using age, sex, health insurance status, family income, principal diagnosis, 13 Charlson Comorbidity Index conditions, atrial fibrillation, hospital teaching status, hospital bed size, distance to the hospital, hospital site indicator, and interactions between these variables. † The Elixhauser index was used to calculate the propensity score. ‡ Including all of the covariates for direct risk adjustment in the entire study population. 11] ), the differences became attenuated over time in both studies. However, despite the narrowing mortality gap in our study, the differences persisted through 1 year, which is consistent with the fact that patients with stroke who opt for aggressive treatment may live months or years with continued supportive care and that more intensive treatment may produce a short-term or intermediate-term survival benefit. In a recent study (37) , black Medicare patients with stroke had a short-term (30-day) mortality benefit (4.4%), after which the survival advantage decreased over time (to 0.6% at 1 year) and eventually reversed after 2 years of follow-up (to a 1.2% advantage for white patients).
The mortality differences are unlikely to be due to disparities in the delivery of effective care, because most research suggests that black patients have poorer access to and adherence to evidence-based treatment (11, 38) . Although we had limited information relating to evidencebased process measures, we observed that fewer black patients received thrombolytic therapy, which is consistent with previous studies (11, 39) . In addition, our data emphasize the limitations of using stroke mortality rates as a measure of quality; indiscriminate use would imply that black patients had better quality of care than white patients (40, 41) . This is a concern because stroke mortality is a common outcome measure in clinical trials, and inpatient stroke mortality is the most common publicly reported measure used to judge the quality of stroke care. The Centers for Medicare & Medicaid Services are considering including 30-day ischemic stroke mortality as one of its publicly reported measures.
Although we have no information on advance directives or patient or family preferences, our results highlight the potential importance of value-laden end-of-life decisions on survival outcomes in stroke care. This involves the complex process of shared decision-making and deliberation to arrive at treatment decisions with end-of-life implications. More research is required to develop methods for measuring the quality of these preference-sensitive decisions for seriously ill patients with stroke. Such methods would need to capture the degree of truly informed patient choice, adequacy of physician communication, attention to health literacy, and respect for individual spiritual beliefs. The quality of these decisions may differ by race, as suggested by a recent study (42) that found that white patients with cancer received end-of-life care consistent with their preferences more frequently than black patients. The policy push toward patient-centered care will also require us to confront the possibility that well-informed patients who decide to forgo life-prolonging treatments and allow a natural death might receive excellent-quality care but have higher mortality than poorly informed patients who decide to use life-prolonging treatments (43).
Because we used administrative data, we could not adjust for admission stroke severity, measure disability, or functional status. We do not believe that a lower severity of stroke in black patients (for example, as a result of more small-vessel vs. large-vessel or cardioembolic disease) explains our findings. First, we used several risk adjustment methods, including the Charlson Comorbidity Index, the Elixhauser index, the presence of atrial fibrillation, and present-on-admission diagnoses, to improve mortality risk adjustment and provide a more accurate assessment of the relationship between race and mortality risk. Second, after adjustment for the probability of dying in the hospital, the ICU admission and mechanical ventilation rates were similar between black and white patients, which suggests that the groups had similar proportions of severe strokes and need for respiratory support. Third, research (3, 4) has shown that black patients have more severe deficits at presentation, a confounding variable that would increase rather than decrease mortality in black patients. Finally, research (9, 10) has also shown that black patients aged 65 years or older have lower adjusted 30-day mortality than white patients after being hospitalized for several conditions, including congestive heart failure, acute myocardial infarction, hip fracture, and gastrointestinal bleeding, which suggests something more systemic than diseasespecific confounding. Further research is needed to confirm these findings.
Our study has additional limitations. First, it is descriptive in nature. Although we observed more aggressive end-of-life treatment and lower mortality in black patients, a causal relationship cannot be established with our study design. However, describing this pattern brings the literature closer to identifying the underlying sources of disparities in stroke outcomes. Second, the ICD-9-CM procedure codes might underestimate the prevalence of potential life-sustaining interventions and thrombolytic therapy. However, no data suggest (and we have no reason to believe) that these procedures would be coded differently by race. Third, we used data from patients who live in urban areas of New York, and the generalizability of our findings, especially to rural areas and to other states, remains to be established. Fourth, because up to 50% of stroke deaths occur outside the hospital setting (44), a racially disproportionate number of out-of-hospital deaths could have an
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Racial Differences in Mortality Among Patients With Acute Ischemic Stroke www.annals.orgeffect on mortality rates calculated from hospital records. Fifth, studies (5, 31, 45) have shown an excess burden of stroke, particularly among young and middle-aged patients. Because most of our study patients were aged 65 years or older, survivor bias may exist if older black patients differed from older white patients. However, we stratified our analysis by age group and observed a consistent pattern of lower risk for death among black patients in each age stratum. Finally, propensity score methods can only adjust for observed confounders (22) ; unmeasured residual confounders, for which we could not adjust, could have been present.
In conclusion, black patients hospitalized with acute ischemic stroke had lower mortality rates than their white counterparts, an effect that persisted but attenuated over the year after the initial hospitalization. A racial effect contributes to this mortality difference, which may be explained by the differential use of intensive treatment in seriously ill patients with stroke. Future research should focus on understanding what drives the racial variations in stroke care and developing optimal approaches for promoting patient-centered decision-making, including the ability to recognize, explore, and respect the cultural norms that each patient and family bring to every clinical encounter. 
APPENDIX Propensity Score
We used propensity scores to balance the baseline characteristics between black and white patients. An important factor in constructing propensity score models is the multilevel structure of the data. First, patients were clustered by hospitals. Second, because treatment patterns can vary by hospital, patients at the same hospital might have been treated more homogenously than those at different hospitals. Finally, black patients often lived in different neighborhoods than white patients and may have systematically used different hospitals. As a result, the observed differences in mortality and acute stroke treatment could be a combination of both a racial and a hospital effect.
Black and white patients should ideally be matched on both propensity score and admitting hospital, to minimize both between-patient and between-hospital practice variation. Patients with stroke were treated at 164 hospitals in New York. However, nearly one quarter of those hospitals did not treat either black or white patients with stroke during the study period (5 hospitals treated only black patients and 32 hospitals treated only white patients with stroke). Therefore, we could not match on propensity score across race for all hospitals. Instead, a partial pooling approach was used, which borrows patient information from different hospitals and incorporates hospital-specific information in the model (25) . This method allows comparison of patients from different hospitals as long as the hospital-specific characteristics are similar.
We estimated the propensity score by using a multivariate logistic regression model in which the dependent variable was race (1 for black and 0 for white) and independent variables were patient sociodemographic, disease, and comorbid condition characteristics; hospital characteristics; hospital site indicators; and 2-way interactions between these variables. Variables were included even if they were weakly associated with the dependent variable. A c-statistic of 0.96 indicated excellent discrimination of a patient's race on the basis of the model. The estimated propensity score was then converted into deciles and included as a variable in the regression model. Inclusion of propensity score deciles as a covariate facilitated a parsimonious regression model and minimized the differences in baseline characteristics between black and white patients.
We checked both the overall and within-hospital balance. Appendix Table 1 shows the P values before and after adjustment for propensity score deciles. Not all P values are statistically significant, which indicates overall balance for black and white patients. A similar check was performed for each hospital; withinhospital balance was achieved for 69 of 71 hospitals (97%). One hospital showed imbalance for distance and another for Medicaid insurance.
We examined the overlap in the distribution of propensity score for black and white patients. As expected, the distributions are different. Appendix Figure 1 shows nearly complete overlap in the distribution of propensity scores for the 2 racial groups after extreme values (0% or 100% probability of being either black or white) and hospitals with a small number of patients were excluded. The propensity scores ranged from 0.001 to 0.999 and 0.001 to 0.996 for black and white patients, respectively.
Although we achieved balance and nearly complete overlap for propensity score distributions, excluding patients from the propensity score analysis may have introduced bias into the study. Appendix Table 2 compares baseline characteristics and mortality among patients included in the propensity score analysis with these values in the entire study sample. The black patients in our analysis did not significantly differ (statistically or clinically) from the entire black sample; however, the white patients in our analysis were younger and had fewer comorbid conditions than the entire white sample. As a result, the white patients in the propensity score subsample had substantially lower mortality rates. This suggests that the propensity score analysis might give a conservative estimate of the racial effect on mortality because of the exclusion of older and sicker white patients. Regardless, it is reassuring that our conservative approach still demonstrated a lower risk for death among black patients, consistent with the direct risk adjustment model that included the entire study population and the propensity score model that used the Elixhauser index.
Consistency Across Hospitals
Patients in the same hospital can be expected to receive more similar treatment than patients in different hospitals. This is the basis for incorporating the multilevel structure of the data when constructing a propensity score model and for using the robust sandwich estimator in the Cox proportional hazard model to account for within-hospital correlation. We checked the consistency across hospitals by repeating the Cox model for each hospital. Individual hospital estimates could change; for example, the hazard ratio switched direction from less than 1 (a lower risk
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www.annals.orgfor death) to greater than 1 (a higher risk for death). However, about two thirds of the hospitals (65%) showed a consistent pattern of lower risk for death for black patients. Of note, the CIs were wide because of the small number of observations from each hospital.
Proportional Hazards Assumption
The interpretation of the hazard ratio depends on whether the premise of the proportional hazards assumption is met. In our analysis, this means that the effects of race are constant over time. One way to assess the proportional hazards assumption is to plot the log negative log of the Kaplan-Meier estimates of the survival function versus the log of survival time. Constant hazard ratios should result in a graph with parallel lines. Appendix Figure 2 shows parallel lines of log-negative-log survival curves for both black and white patients. Another method for assessing the proportional hazards assumption would be to visually assess whether the effect of race changes over time by using a plot of the Schoenfeld residuals by time. Appendix Figure 3 shows a smooth line in the Schoenfeld residuals plot, with an intercept and a slope of approximately 0. Thus, neither method shows any evidence that the proportional hazards assumption for race was violated. 
Appendix
